Immunotherapy for non-small cell lung cancer

被引：11
|
作者：
Vafadar, Sam [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol, Tampa, FL 33612 USA
来源：
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2019年 / 32卷 / 09期
关键词：
non-small cell lung cancer; immunotherapy; nivolumab; pembrolizumab; atezolizumab; durvalumab; ADVERSE EVENTS; OPEN-LABEL; PEMBROLIZUMAB; NIVOLUMAB; DOCETAXEL;
D O I：
10.1097/01.JAA.0000569792.99069.e6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Immunotherapy is a new genre of treatment for patients with advanced cancer. Initially approved for use in metastatic melanoma, immunotherapy has found a significant place in treating non-small cell lung cancer (NSCLC). Clinical trials using several combinations of immunotherapy are underway to help to determine the best treatment for specific patient groups. This article reviews approved uses of immunotherapy for NSCLC, immune-related toxicities, and explores the future direction of this treatment.
引用
收藏
页码：37 / 42
页数：6
相关论文
共 50 条
  • [31] The State of the Art in Non-Small Cell Lung Cancer Immunotherapy
    Seetharamu, Nagashree
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2014, 26 (01) : 26 - 35
  • [32] Neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Xie, Hui
    Shi, Xuejun
    Wang, Guangshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2521 - 2536
  • [33] New strategies in immunotherapy for non-small cell lung cancer
    Carrizosa, Daniel R.
    Gold, Kathryn A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 553 - 559
  • [34] THE SOCIAL VALUE OF IMMUNOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Sullivan, J.
    Ward, Sexton A.
    Korytowsky, B.
    Peneva, D.
    Benner, J.
    Lakdawalla, D. N.
    Bolinder, B.
    Figlin, R. A.
    Jena, A. B.
    VALUE IN HEALTH, 2016, 19 (03) : A167 - A167
  • [35] Neoadjuvant Immunotherapy for Patients with non-small cell Lung Cancer
    Luecke, E.
    Ganzert, C.
    Waesche, A.
    Walles, T.
    Schreiber, J.
    PNEUMOLOGIE, 2020, 74 : S74 - S75
  • [36] Immunotherapy through the Lens of Non-Small Cell Lung Cancer
    Stanley, Robyn
    Flanagan, Saoirse
    O'Reilly, David
    Kearney, Ella
    Naidoo, Jarushka
    Dowling, Catriona M.
    CANCERS, 2023, 15 (11)
  • [37] Biomarkers for immunotherapy resistance in non-small cell lung cancer
    Rother, Catriona
    John, Tom
    Wong, Annie
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [38] Current status of immunotherapy for non-small cell lung cancer
    Yang, Tao
    Xiong, Yilin
    Zeng, Yufei
    Wang, Yan
    Zeng, Jing
    Liu, Jie
    Xu, Shangfu
    Li, Li-Sheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] First line Immunotherapy for Non-Small Cell Lung Cancer
    Nasser, Nicola J.
    Gorenberg, Miguel
    Agbarya, Abed
    PHARMACEUTICALS, 2020, 13 (11) : 1 - 24
  • [40] Immunotherapy in surgically resectable non-small cell lung cancer
    Owen, Dwight
    Chaft, Jamie E.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S404 - S411
12345